Genetics of gestational trophoblastic neoplasia: an update for the clinician

被引:9
作者
Alifrangis, Constantine [1 ]
Seckl, Michael J. [1 ]
机构
[1] Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Screening &, London W6 8RF, England
关键词
genetics; gestational trophoblastic disease; molecular pathology; RECURRENT HYDATIDIFORM MOLE; GROWTH-FACTOR RECEPTOR; NLRP7; MUTATIONS; CHORIOCARCINOMA; EXPRESSION; DISEASE; METHYLATION; MANAGEMENT; PLACENTA; TUMOR;
D O I
10.2217/FON.10.153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gestational trophoblastic disease is a spectrum of disorders ranging from premalignant hydatidiform moles through to malignant invasive moles, choriocarcinoma and rare placental site trophoblastic tumor. The latter are often collectively referred to as gestational trophoblastic tumors or neoplasia (GTN). Although most women can expect to be cured of their disease, many interesting questions arise in the management of gestational trophoblastic disease. Current issues pertain to diagnosis of GTN, predicting progression from hydatidiform moles to GTN and the emergence of drug resistance in GTN. Our understanding of the genetics of GTN has helped us answer some of these questions but many remain unresolved. This article seeks to address recent advances in the genetics of GTN in relation to diagnosis, etiology, prognosis and treatment.
引用
收藏
页码:1915 / 1923
页数:9
相关论文
共 67 条
  • [31] Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
    McNeish, IA
    Strickland, S
    Holden, L
    Rustin, GJS
    Foskett, M
    Seckl, MJ
    Newlands, ES
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1838 - 1844
  • [32] Mitchell H, 2006, J REPROD MED, V51, P868
  • [33] Genetic mapping of a maternal locus responsible for familial hydatidiform moles
    Moglabey, YB
    Kircheisen, R
    Seoud, M
    El Mogharbel, N
    Van den Veyver, I
    Slim, R
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (04) : 667 - 671
  • [34] Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
    Mok, Tony S.
    Wu, Yi-Long
    Thongprasert, Sumitra
    Yang, Chih-Hsin
    Chu, Da-Tong
    Saijo, Nagahiro
    Sunpaweravong, Patrapim
    Han, Baohui
    Margono, Benjamin
    Ichinose, Yukito
    Nishiwaki, Yutaka
    Ohe, Yuichiro
    Yang, Jin-Ji
    Chewaskulyong, Busyamas
    Jiang, Haiyi
    Duffield, Emma L.
    Watkins, Claire L.
    Armour, Alison A.
    Fukuoka, Masahiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) : 947 - 957
  • [35] Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines
    Mparmpakas, Dionisis
    Zachariades, Elena
    Foster, Helen
    Kara, Anjeli
    Harvey, Amanda
    Goumenou, Anastasia
    Karteris, Emmanouil
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (01) : 65 - 69
  • [36] Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans
    Murdoch, S
    Djuric, U
    Mazhar, B
    Seoud, M
    Khan, R
    Kuick, R
    Bagga, R
    Kircheisen, R
    Ao, A
    Ratti, B
    Hanash, S
    Rouleau, GA
    Slim, R
    [J]. NATURE GENETICS, 2006, 38 (03) : 300 - 302
  • [37] Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285
  • [38] Gestational trophoblastic neoplasia management: an update
    Ngan, Sarah
    Seckl, Michael J.
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (05) : 486 - 491
  • [39] NLR family pyrin domain-containing 7 (NLRP7), NLR FAMILY PYRIN DOM
  • [40] Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts
    Novakovic, B.
    Rakyan, V.
    Ng, H. K.
    Manuelpillai, U.
    Dewi, C.
    Wong, N. C.
    Morley, R.
    Down, T.
    Beck, S.
    Craig, J. M.
    Saffery, R.
    [J]. MOLECULAR HUMAN REPRODUCTION, 2008, 14 (09) : 547 - 554